

He also led teams of lab-based scientists, established and managed biotech and academic collaborations, and supported business development deals.Īt CCI Dr Sheppard leads the T Cell Engineering Lab (TCEL), facilitates partnerships with biotech companies, and leads the strategy for our clinical stage Mesothelin-specific CAR-T program. During his time in industry Dr Sheppard held positions of increasing responsibility leading programs through drug development milestones and into the clinic, opening Investigational New Drug (IND) applications and leading strategy for Ph1/2 clinical trials. Following a Bill & Melinda Gates Foundation funded Postdoc at the University of Oxford Dr Sheppard joined the Pharmaceutical Industry working first at Pfizer in the UK and California, and subsequently for GSK in Philadelphia and Sydney, Australia, followed by a period at Tmunity Therapeutics a CCI Spinout biotech company.
#Tcel company how to#
He subsequently obtained his D.Phil in Vaccine & Adjuvant Research from the University of Oxford in 2007. CYPRUS GLOBAL WHY TCEL FAMILY 'Imagine TCEL as your interim COO who knows how to get things done in Cyprus in the most efficient way. degree in Immunology with Study in Industry from the University of Bristol (UK) in 2002, with his industry year spent at GSK. Since 2015 Dr Sheppard has worked exclusively on cellular immunotherapies for cancer (CAR-T, TCR-T and CAR-NK).ĭr Sheppard obtained a B.Sc.

This experience spans multiple modalities: small molecule compounds, biologics and cell & gene therapies, as well as multiple geographies: UK, Australia, California and Philadelphia. Sheppard, D.Phil Adjunct Associate Professor of Pathology & Laboratory Medicine, Head of the T Cell Engineering Lab (TCEL), Director for Research Technologies & Innovationĭr Sheppard joined the Center for Cellular Immunotherapies in October 2019 bringing with him a wealth of experience from over a dozen years spent in Big Pharma and Biotechnology companies focused on discovery and clinical translation of innovative medicines. Montgomery is Co-President of the Tulane Public Interest Law Foundation (PILF) and is a junior member of the Tulane Environmental Law Journal.Neil C. In addition to being recognized at the annual Journal banquet, he will receive an award of $1,000.Ī three-person panel judged the competition- Attorney Suzette Bagneris, Tulane Law Prof. Lauren Godshall, and former Tulane Environmental Law Journal Editor Thuy Le (L’20) - and selected Montgomery’s comment due to its thoughtful analysis, the clear and comprehensive way in which it presented its argument, and the relevancy of the topic to current environmental issues. The TCEL Prize is awarded annually to the best student comment submitted to the Journal. Montgomery (L’22) wrote about the issue under the theory of unjust enrichment in a comment titled “Polluter Disgorges: Climate Accountability and the Law of Unjust Enrichment,” which will be published in Volume 35 of the Tulane Environmental Law Journal during the coming academic year. William Montgomery, a second-year law student, has been awarded the Tulane Center for Environmental Law Prize for his forward-thinking analysis of climate accountability issues. Tulane Center for Environmental Law Director Mark Davis and William Montgomery (L'22), the winner of the TCEL writing prize for his comment on climate accountability.
